Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sun Dec 18 19:20:48 UTC 2022
by
admin
on
Sun Dec 18 19:20:48 UTC 2022
|
| Protein Type | VIRAL STRUCTURAL PROTEIN |
| Protein Sub Type | VIRAL ENVELOPE PROTEIN |
| Sequence Origin | VIRAL |
| Sequence Type | COMPLETE |
| Record UNII |
8R39BE7TJJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8R39BE7TJJ
Created by
admin on Sun Dec 18 19:20:48 UTC 2022 , Edited by admin on Sun Dec 18 19:20:48 UTC 2022
|
PRIMARY |
| From | To |
|---|---|
| 3_1070 | 3_1114 |
| 3_1020 | 3_1031 |
| 3_828 | 3_839 |
| 3_726 | 3_748 |
| 3_731 | 3_737 |
| 3_650 | 3_659 |
| 3_605 | 3_637 |
| 3_526 | 3_578 |
| 3_468 | 3_476 |
| 3_379 | 3_513 |
| 3_367 | 3_420 |
| 3_324 | 3_349 |
| 3_279 | 3_289 |
| 3_119 | 3_154 |
| 3_3 | 3_124 |
| 2_1070 | 2_1114 |
| 2_1020 | 2_1031 |
| 2_828 | 2_839 |
| 2_726 | 2_748 |
| 2_731 | 2_737 |
| 2_650 | 2_659 |
| 2_605 | 2_637 |
| 2_526 | 2_578 |
| 2_468 | 2_476 |
| 2_379 | 2_513 |
| 2_367 | 2_420 |
| 2_324 | 2_349 |
| 2_279 | 2_289 |
| 2_119 | 2_154 |
| 2_3 | 2_124 |
| 1_1070 | 1_1114 |
| 1_1020 | 1_1031 |
| 1_828 | 1_839 |
| 1_726 | 1_748 |
| 1_731 | 1_737 |
| 1_650 | 1_659 |
| 1_605 | 1_637 |
| 1_526 | 1_578 |
| 1_468 | 1_476 |
| 1_379 | 1_513 |
| 1_367 | 1_420 |
| 1_324 | 1_349 |
| 1_279 | 1_289 |
| 1_119 | 1_154 |
| 1_3 | 1_124 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_5 |
| N | 1_49 |
| N | 1_62 |
| N | 1_110 |
| N | 1_137 |
| N | 1_153 |
| N | 1_222 |
| N | 1_270 |
| N | 1_319 |
| N | 1_331 |
| N | 1_591 |
| N | 1_604 |
| N | 1_645 |
| N | 1_697 |
| N | 1_705 |
| N | 1_789 |
| N | 1_1062 |
| N | 1_1086 |
| N | 1_1122 |
| N | 1_1146 |
| N | 1_1161 |
| N | 1_1182 |
| N | 2_5 |
| N | 2_49 |
| N | 2_62 |
| N | 2_110 |
| N | 2_137 |
| N | 2_153 |
| N | 2_222 |
| N | 2_270 |
| N | 2_319 |
| N | 2_331 |
| N | 2_591 |
| N | 2_604 |
| N | 2_645 |
| N | 2_697 |
| N | 2_705 |
| N | 2_789 |
| N | 2_1062 |
| N | 2_1086 |
| N | 2_1122 |
| N | 2_1146 |
| N | 2_1161 |
| N | 2_1182 |
| N | 3_5 |
| N | 3_49 |
| N | 3_62 |
| N | 3_110 |
| N | 3_137 |
| N | 3_153 |
| N | 3_222 |
| N | 3_270 |
| N | 3_319 |
| N | 3_331 |
| N | 3_591 |
| N | 3_604 |
| N | 3_645 |
| N | 3_697 |
| N | 3_705 |
| N | 3_789 |
| N | 3_1062 |
| N | 3_1086 |
| N | 3_1122 |
| N | 3_1146 |
| N | 3_1161 |
| N | 3_1182 |
| O | 1_311 |
| O | 1_313 |
| O | 2_311 |
| O | 2_313 |
| O | 3_311 |
| O | 3_313 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
LIGAND->TARGET |
|
||
|
|
INHIBITOR -> TARGET |
BINDING
|
||
|
|
INHIBITOR -> TARGET |
BINDING
|
||
|
|
LIGAND->TARGET |
Binding studies have demonstrated that ADG20 competes with ACE-2 for binding to SARS-CoV-2 S protein thus preventing viral entry
|
||
|
|
INHIBITOR -> TARGET |
BRII-198 has no or moderately reduced binding activity (approximately two to three-fold) to
human Fc? receptors (Fc?R I, Fc?R IIa, Fc?R IIb, Fc?R IIIa.
BINDING
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|